|
125 Companies |
|
160 Products |
|
160 Products |
|
105 Mechanisms of Action |
|
14 Trials |
|
4687 News |
|
| 12345678910111213...9394» |
- | Phase classification: Vertebroplasty Compared With a Sham-procedure for Painful Acute Osteoporotic Vertebral Fractures (clinicaltrials.gov) - May 6, 2025
P=N/A, N=52, Completed, Sponsor: Spine Centre of Southern Denmark
Phase classification: P4 --> P=N/A
- | Phase classification: Evaluation of Efficacy and Safety of Autologous MSCs Combined to Biomaterials to Enhance Bone Healing (clinicaltrials.gov) - Jan 23, 2025
P2, N=30, Completed, Sponsor: Institut National de la Sant
Phase classification: P4 --> P=N/A Phase classification: P1/2 --> P2
- | Trial withdrawal: PASCAL: Safety and Complications, Experience After 1301 Consecutive Cases (clinicaltrials.gov) - May 30, 2024
P=N/A, N=0, Withdrawn, Sponsor: Asociaci
Phase classification: P1/2 --> P2 Completed --> Withdrawn
- Exparel (bupivacaine liposome injectable suspension) / Pacira
Enrollment change: Study of A Long Lasting Local Anesthestic for Hand, Wrist or Finger Surgery (clinicaltrials.gov) - May 21, 2024
P4, N=37, Terminated, Sponsor: Jose Soberon, MD
Completed --> Withdrawn N=90 --> 37
- || ibuprofen / Generic mfg.
Trial completion: SNIF: Outcomes Associated With Application of a Normothermia Protocol in Patients With Severe Neurological Insult and Fever (clinicaltrials.gov) - Jan 24, 2024
P=N/A, N=10, Completed, Sponsor: University of Washington
N=90 --> 37 Terminated --> Completed
- | Enrollment change: The Efficacy of Crotaline Fab Antivenom for Copperhead Snake Envenomations (clinicaltrials.gov) - Dec 1, 2023
P4, N=13, Terminated, Sponsor: Wake Forest University Health Sciences
Terminated --> Completed N=25 --> 13
- | Trial completion date, Trial primary completion date: Atypical Fracture Cohort Study (clinicaltrials.gov) - May 23, 2023
P=N/A, N=300, Recruiting, Sponsor: University Health Network, Toronto
N=25 --> 13 Trial completion date: Dec 2022 --> Dec 2026 | Trial primary completion date: Dec 2020 --> Dec 2025
- | vancomycin / Generic mfg.
Trial completion: POWI: Prevention of Neurosurgical Wound Infections (clinicaltrials.gov) - Apr 30, 2019
P=N/A, N=214, Completed, Sponsor: Oregon Health and Science University
Trial completion date: Dec 2022 --> Dec 2026 | Trial primary completion date: Dec 2020 --> Dec 2025 Active, not recruiting --> Completed
- | Trial completion, Metastases: Home Study of an Advanced Upper Limb Prosthesis (clinicaltrials.gov) - Apr 30, 2019
P=N/A, N=52, Completed, Sponsor: VA Office of Research and Development
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Enrollment change: Pediatric Femur Research Project (clinicaltrials.gov) - Apr 26, 2019
P=N/A, N=48, Completed, Sponsor: Washington University School of Medicine
Active, not recruiting --> Completed Active, not recruiting --> Completed | N=145 --> 48
- | Phase classification: Role of SPECT in Radiotherapy of Lung Cancer and Toxicity Evaluation (clinicaltrials.gov) - Apr 25, 2019
P=N/A, N=71, Completed, Sponsor: University of Aarhus
Active, not recruiting --> Completed | N=145 --> 48 Phase classification: P2 --> P=N/A
- ||| NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Optimizing Plyometric Training for Functional Recovery Post-ACL Reconstruction (clinicaltrials.gov) - Apr 25, 2019
P=N/A, N=47, Completed, Sponsor: University of Montana
Phase classification: P2 --> P=N/A Recruiting --> Completed | N=80 --> 47 | Trial completion date: Sep 2018 --> Dec 2018 | Trial primary completion date: Sep 2018 --> Dec 2018
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change: Outcomes Following Neuropsychological Intervention in Acquired Brain Injury Outpatients With Executive Dysfunction (clinicaltrials.gov) - Apr 25, 2019
P=N/A, N=18, Completed, Sponsor: University of Manitoba
Recruiting --> Completed | N=80 --> 47 | Trial completion date: Sep 2018 --> Dec 2018 | Trial primary completion date: Sep 2018 --> Dec 2018 Enrolling by invitation --> Completed | N=36 --> 18
- | Phase classification: [Trial of device that is not approved or cleared by the U.S. FDA] (clinicaltrials.gov) - Apr 23, 2019
P=N/A, N=0, Withheld, Sponsor: [Redacted]
Enrolling by invitation --> Completed | N=36 --> 18 Phase classification: P2/3 --> P=N/A
- | epinephrine / Generic mfg.
Trial completion, Trial completion date, Trial primary completion date, Surgery: Lidocaine With Epinephrine vs. Bupivacaine With Epinephrine as Local Anesthetic Agents in Wide-awake Hand Surgery (clinicaltrials.gov) - Apr 23, 2019
P=N/A, N=61, Completed, Sponsor: St. Mary's Research Center, Canada
Phase classification: P2/3 --> P=N/A Recruiting --> Completed | Trial completion date: Dec 2015 --> Apr 2019 | Trial primary completion date: Oct 2015 --> Apr 2019
- | Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
Enrollment change, Trial completion date, Trial withdrawal, Trial primary completion date: Botulinum Toxin for Carpal Tunnel Syndrome (clinicaltrials.gov) - Apr 20, 2019
P2, N=0, Withdrawn, Sponsor: University of Minnesota - Clinical and Translational Science Institute
Recruiting --> Completed | Trial completion date: Dec 2015 --> Apr 2019 | Trial primary completion date: Oct 2015 --> Apr 2019 N=20 --> 0 | Trial completion date: Jun 2018 --> Oct 2018 | Active, not recruiting --> Withdrawn | Trial primary completion date: May 2018 --> Oct 2018
- | Phase classification: Immobilization in External Rotation After First Time Anterior Shoulder Dislocation (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=50, Completed, Sponsor: University of Colorado, Denver
N=20 --> 0 | Trial completion date: Jun 2018 --> Oct 2018 | Active, not recruiting --> Withdrawn | Trial primary completion date: May 2018 --> Oct 2018 Phase classification: P3 --> P=N/A
- | Trial completion, Phase classification, Enrollment change: Rehabilitation of the Upper Extremity With Enhanced Proprioceptive Feedback Following Incomplete Spinal Cord Injury (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=13, Completed, Sponsor: Oregon Health and Science University
Phase classification: P3 --> P=N/A Active, not recruiting --> Completed | Phase classification: P1/2 --> PN/A | N=20 --> 13
- | cephalexin / Generic mfg.
Enrollment change: Prophylactic Use of Antibiotics for Through and Through Lacerations of the Lip (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=4, Terminated, Sponsor: University of Pennsylvania
Active, not recruiting --> Completed | Phase classification: P1/2 --> PN/A | N=20 --> 13 N=10 --> 4
- ||| Trial completion, Enrollment change: Prospective Evaluation of Aeromedical EMS Ultrasound in Major Trauma Victims (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=34, Completed, Sponsor: The University of Texas Health Science Center, Houston
N=10 --> 4 Active, not recruiting --> Completed | N=500 --> 34
- | Trial completion, Enrollment change: Restoration of Life Role Participation Through Cognitive and Motor Training for TBI (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=5, Completed, Sponsor: Malcom Randall VA Medical Center
Active, not recruiting --> Completed | N=500 --> 34 Active, not recruiting --> Completed | N=24 --> 5
- | Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Treatment of Acute and Chronic Ligament and Tendon Injuries With Platelet Rich Plasma (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=30, Completed, Sponsor: Stanford University
Active, not recruiting --> Completed | N=24 --> 5 Recruiting --> Completed | N=100 --> 30 | Trial completion date: Dec 2019 --> Mar 2019 | Trial primary completion date: Dec 2018 --> Mar 2019
- Enrollment change, Trial completion date, Trial termination, Trial primary completion date: Outcomes Study of the TM Humeral Stem Used in Primary, Total or Hemi Shoulder Arthroplasty (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=67, Terminated, Sponsor: Zimmer Biomet
Recruiting --> Completed | N=100 --> 30 | Trial completion date: Dec 2019 --> Mar 2019 | Trial primary completion date: Dec 2018 --> Mar 2019 N=120 --> 67 | Trial completion date: Dec 2024 --> Dec 2018 | Recruiting --> Terminated | Trial primary completion date: Dec 2023 --> Dec 2018; Business decision was made to remove the CE mark from this product, thus prompting the closing of this study.
- | Phase classification: Psychological and Psychosocial Intervention With War-Affected Children (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=50, Completed, Sponsor: Queen's University, Belfast
N=120 --> 67 | Trial completion date: Dec 2024 --> Dec 2018 | Recruiting --> Terminated | Trial primary completion date: Dec 2023 --> Dec 2018; Business decision was made to remove the CE mark from this product, thus prompting the closing of this study. Phase classification: P2 --> P=N/A
- | Trial completion: Bowel Care and Cardiovascular Function After Spinal Cord Injury (clinicaltrials.gov) - Apr 20, 2019
P4, N=13, Completed, Sponsor: Simon Fraser University
Phase classification: P2 --> P=N/A Recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change: Intervention to Prevent Fall Injuries to Young Children in the Home (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=100, Completed, Sponsor: University of Guelph
Recruiting --> Completed Recruiting --> Completed | N=100000 --> 100
- | oxandrolone / Generic mfg.
Enrollment change, Trial withdrawal: RCT of Goal-directed Iron Supplementation of Anemic, Critically Ill Trauma Patients, With and Without Oxandrolone (clinicaltrials.gov) - Apr 19, 2019
P2, N=0, Withdrawn, Sponsor: Denver Health and Hospital Authority
Recruiting --> Completed | N=100000 --> 100 N=40 --> 0 | Completed --> Withdrawn
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial primary completion date: Comparison of Two Psycho-educational Family Group Interventions for Persons With SCI and Their Caregivers (clinicaltrials.gov) - Apr 19, 2019
P=N/A, N=38, Completed, Sponsor: St. Luke's Rehabilitation Institute
N=40 --> 0 | Completed --> Withdrawn Active, not recruiting --> Completed | N=64 --> 38 | Trial primary completion date: Dec 2018 --> Apr 2019
- | NN1213 / Novo Nordisk
Trial completion: Pathogenesis of Atypical Femur Fractures on Long Term Bisphosphonate Therapy (clinicaltrials.gov) - Apr 19, 2019
P=N/A, N=738, Completed, Sponsor: Henry Ford Health System
Active, not recruiting --> Completed | N=64 --> 38 | Trial primary completion date: Dec 2018 --> Apr 2019 Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Enrollment change, Trial termination: EERAADS: A Randomized Evaluation of Emergent Immobilization in External Rotation in the Management of Acute Anterior Dislocations of the Shoulder (clinicaltrials.gov) - Apr 19, 2019
P=N/A, N=3, Terminated, Sponsor: St. Michael's Hospital, Toronto
Active, not recruiting --> Completed N=75 --> 3 | Recruiting --> Terminated; Slow patient enrolment
- ||| NN1213 / Novo Nordisk
Trial completion, HEOR: Health Outcomes After Locomotor Training in Spinal Cord Injury (clinicaltrials.gov) - Apr 19, 2019
P=N/A, N=80, Completed, Sponsor: Stony Brook University
N=75 --> 3 | Recruiting --> Terminated; Slow patient enrolment Recruiting --> Completed
- | Prolia (denosumab) / Amgen, NN1213 / Novo Nordisk
Trial completion, HEOR: Effectiveness or Orthopedic Intervention in Osteoporosis Management After a Fracture of the Hip With Cost-Benefit Analysis (clinicaltrials.gov) - Apr 19, 2019
P=N/A, N=200, Completed, Sponsor: Shaare Zedek Medical Center
Recruiting --> Completed Recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change: the Treatment of Human Bone Marrow Mesenchymal Stem Cells in Ocular Corneal Burn (clinicaltrials.gov) - Apr 11, 2019
P2, N=16, Completed, Sponsor: Sun Yat-sen University
Recruiting --> Completed Not yet recruiting --> Completed | N=100 --> 16
- | Trial completion, Trial completion date, Metastases: Supraspinal Control of Lower Urinary Tract Function in Healthy Controls and Patients With Bladder Dysfunction (clinicaltrials.gov) - Mar 18, 2019
P=N/A, N=91, Completed, Sponsor: University of Zurich
Not yet recruiting --> Completed | N=100 --> 16 Recruiting --> Completed | Trial completion date: Dec 2014 --> Dec 2018
- | Enrollment change, Trial termination: Evaluation of Tolerability and Efficacy of Erythropoietin (EPO) Treatment in Spinal Shock: Comparative Study Versus Methylprednisolone (MP) (clinicaltrials.gov) - Mar 14, 2019
P3, N=10, Terminated, Sponsor: Niguarda Hospital
Recruiting --> Completed | Trial completion date: Dec 2014 --> Dec 2018 N=100 --> 10 | Suspended --> Terminated; Italian Medicines Agency decision
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: VROT: Virtual Reality Pain Control Orthopedic Trauma (clinicaltrials.gov) - Mar 13, 2019
P=N/A, N=211, Completed, Sponsor: National Institute of General Medical Sciences (NIGMS)
N=100 --> 10 | Suspended --> Terminated; Italian Medicines Agency decision Active, not recruiting --> Completed | Trial completion date: Dec 2018 --> Jun 2018 | Trial primary completion date: Dec 2018 --> Jun 2018
- | Trial completion: Inflammation and the Host Response to Injury (Burns) (clinicaltrials.gov) - Mar 7, 2019
P=N/A, N=280, Completed, Sponsor: Massachusetts General Hospital
Active, not recruiting --> Completed | Trial completion date: Dec 2018 --> Jun 2018 | Trial primary completion date: Dec 2018 --> Jun 2018 Active, not recruiting --> Completed
- | Trial completion: Inflammation and the Host Response to Injury (Trauma) (clinicaltrials.gov) - Mar 7, 2019
P=N/A, N=610, Completed, Sponsor: Massachusetts General Hospital
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Enrollment change, Trial withdrawal: Observational Study of Insulin Resistance and Muscle Wasting After Burn Injury (clinicaltrials.gov) - Mar 7, 2019
P=N/A, N=0, Withdrawn, Sponsor: Massachusetts General Hospital
Active, not recruiting --> Completed N=24 --> 0 | Recruiting --> Withdrawn
- | Trial completion: Multicenter Benchmarking of Functional and Psychosocial Outcomes of Pediatric Burn Survivors (clinicaltrials.gov) - Mar 6, 2019
P=N/A, N=3000, Completed, Sponsor: Massachusetts General Hospital
N=24 --> 0 | Recruiting --> Withdrawn Recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Cerament Treatment of Fracture Defects (clinicaltrials.gov) - Mar 4, 2019
P=N/A, N=137, Completed, Sponsor: Johannes Gutenberg University Mainz
Recruiting --> Completed Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial primary completion date: Neurofeedback for Treatment of Central Neuropathic Pain (CNP) in Sub-acute Spinal Cord Injury (SCI) (clinicaltrials.gov) - Mar 1, 2019
P=N/A, N=20, Completed, Sponsor: NHS Greater Glasgow and Clyde
Active, not recruiting --> Completed Recruiting --> Completed | N=60 --> 20 | Trial primary completion date: Aug 2017 --> Nov 2017
- | NN1213 / Novo Nordisk
Trial completion: MUBI: Efficacy and Neural Basis of Music-based Neurological Rehabilitation for Traumatic Brain Injury (clinicaltrials.gov) - Feb 28, 2019
P=N/A, N=40, Completed, Sponsor: Helsinki University
Recruiting --> Completed | N=60 --> 20 | Trial primary completion date: Aug 2017 --> Nov 2017 Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: The Effects of Accelerometer Triggered Functional Electrical Stimulation on Post-Stroke Hemiplegic Shoulder Subluxation (clinicaltrials.gov) - Feb 27, 2019
P=N/A, N=76, Completed, Sponsor: Yonsei University
Active, not recruiting --> Completed Recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: Effect of Methylphenidate on Ecologic Function in Paediatric Acquired Brain Injury Population (clinicaltrials.gov) - Feb 26, 2019
P2, N=34, Completed, Sponsor: Loewenstein Hospital
Recruiting --> Completed Recruiting --> Completed | Trial completion date: Dec 2017 --> Mar 2017 | Trial primary completion date: Dec 2017 --> Jan 2017
- | NN1213 / Novo Nordisk
Enrollment change: Deployment Related Mild Traumatic Brain Injury (mTBI) (clinicaltrials.gov) - Feb 25, 2019
P=N/A, N=750, Completed, Sponsor: The Defense and Veterans Brain Injury Center
Recruiting --> Completed | Trial completion date: Dec 2017 --> Mar 2017 | Trial primary completion date: Dec 2017 --> Jan 2017 N=1500 --> 750
- ||| NN1213 / Novo Nordisk
Trial completion, Enrollment change: CP-STR-01: Tissue Repair Device (VergenixTM STR) in Patients With Epicondylitis (Tennis Elbow) (clinicaltrials.gov) - Feb 20, 2019
P=N/A, N=40, Completed, Sponsor: Collplant
N=1500 --> 750 Recruiting --> Completed | N=20 --> 40
- | Trial completion: Efficacy of Injection Therapy for Lateral Epicondylosis (clinicaltrials.gov) - Feb 18, 2019
P2, N=31, Completed, Sponsor: University of Wisconsin, Madison
Recruiting --> Completed | N=20 --> 40 Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Enrollment change, Trial termination: Oral Rehydration Therapy in Burn Patients (clinicaltrials.gov) - Feb 18, 2019
P1, N=3, Terminated, Sponsor: Johns Hopkins University
Active, not recruiting --> Completed N=40 --> 3 | Enrolling by invitation --> Terminated; Intervention appeared to be associated with increased nausea in some patients.
- | Trial completion: WRIST: A Clinical Trial for the Surgical Treatment of Elderly Distal Radius Fractures (clinicaltrials.gov) - Feb 11, 2019
P=N/A, N=304, Completed, Sponsor: University of Michigan
N=40 --> 3 | Enrolling by invitation --> Terminated; Intervention appeared to be associated with increased nausea in some patients. Active, not recruiting --> Completed